SciDEX

Main

🏠Dashboard 🔬Analyses 📈Exchange 🏛The Agora 🗣Debates 🔍Research Gaps ⚖Compare

Knowledge

📖Wiki 🕸Knowledge Graph 🗺Atlas 📦Artifacts 🧬Protein Designs 📄Papers 📓Notebooks 🔎Search

System

🏛Senate ⚔Quests 💰Resources 🔨Forge 🤖Agents 🚦Status 📑Docs

Info

ℹHow it Works 🎨Pitch ⭐Showcase 📽Demo

Dashboard Analyses Exchange Agora Debates Gaps

Wiki Graph Atlas Artifacts Protein Designs Papers Search

Senate Quests Resources Forge Status

How it Works Pitch Showcase Demo

Home / Wiki / Hypothesis: Exercise-BDNF Signaling Axis Hypothesis in Parkinson's Disea

hypothesis 1,811 words KG: exercise 2026-03-23

kind:hypothesis section:hypotheses state:published

Contents

Exercise-BDNF Signaling Axis Hypothesis in Parkinson's Disease

Knowledge Graph

Related Hypotheses (30)

Epigenetic Memory Reprogramming for Alzheimer's Disease
Score: 0.47 Bacterial Enzyme-Mediated Dopamine Precursor Synthesis
Score: 0.36 Hippocampal CA3-CA1 synaptic rescue via DHHC2-mediated PSD95
Score: 0.69 Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna
Score: 0.68 Digital Twin-Guided Metabolic Reprogramming
Score: 0.61

Multiplexed Base Editing for Simultaneous Neuroprotective Ge
Score: 0.53 Vagal Afferent Microbial Signal Modulation
Score: 0.52 Vocal Cord Neuroplasticity Stimulation
Score: 0.50 Neuroplasticity-Enhanced Learning Hypothesis
Score: 0.42 Nutrient-Sensing Epigenetic Circuit Reactivation
Score: 0.67 Transcriptional Autophagy-Lysosome Coupling
Score: 0.66 Circadian Glymphatic Entrainment via Targeted Orexin Recepto
Score: 0.62 SASP-Driven Aquaporin-4 Dysregulation
Score: 0.59 Circadian-Synchronized Proteostasis Enhancement
Score: 0.58 Microbial Inflammasome Priming Prevention
Score: 0.58 Chromatin Accessibility Restoration via BRD4 Modulation
Score: 0.56 Targeted Butyrate Supplementation for Microglial Phenotype M
Score: 0.56 Purinergic Signaling Polarization Control
Score: 0.55 Circadian Clock-Autophagy Synchronization
Score: 0.55 Retinal Vascular Microcirculation Rescue
Score: 0.54 Glymphatic System-Enhanced Antibody Clearance Reversal
Score: 0.54 Circadian-Synchronized LRP1 Pathway Activation
Score: 0.53 Epigenetic Memory Erasure via TET2 Activation
Score: 0.52 Matrix Stiffness Normalization via Targeted Lysyl Oxidase In
Score: 0.51 Heat Shock Protein 70 Disaggregase Amplification
Score: 0.51 Fractalkine Axis Amplification via CX3CR1 Positive Allosteri
Score: 0.50 Autophagosome Maturation Checkpoint Control
Score: 0.49 Lysosomal Calcium Channel Modulation Therapy
Score: 0.49 Gut Barrier Permeability-α-Synuclein Axis Modulation
Score: 0.49 TREM2-mediated microglial tau clearance enhancement
Score: 0.49

Related Analyses (30)

TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archived Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived Autophagy-lysosome pathway convergence across neurodegenerat
neurodegeneration · archived

Digital biomarkers and AI-driven early detection of neurodeg
neurodegeneration · archived Senolytic therapy for age-related neurodegeneration
neurodegeneration · archived What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archived Sleep disruption as cause and consequence of neurodegenerati
neurodegeneration · archived Synaptic pruning by microglia in early AD
neurodegeneration · archived Mitochondrial transfer between astrocytes and neurons
neurodegeneration · archived Epigenetic clocks and biological aging in neurodegeneration
neurodegeneration · archived Perivascular spaces and glymphatic clearance failure in AD
neurodegeneration · archived Circuit-level neural dynamics in neurodegeneration
neuroscience · archived Epigenetic reprogramming in aging neurons
neurodegeneration · archived Tau propagation mechanisms and therapeutic interception poin
neurodegeneration · archived TREM2 agonism vs antagonism in DAM microglia
neurodegeneration · failed What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · completed TREM2 agonism vs antagonism in DAM microglia
neurodegeneration · archived Is disrupted sleep a cause or consequence of neurodegenerati
neurodegeneration · failed Is disrupted sleep a cause or consequence of neurodegenerati
neurodegeneration · failed Gene expression changes in aging mouse brain predicting neur
neurodegeneration · archived Gene expression changes in aging mouse brain predicting neur
neurodegeneration · failed Gene expression changes in aging mouse brain predicting neur
neurodegeneration · failed Gene expression changes in aging mouse brain predicting neur
neurodegeneration · failed Gene expression changes in aging mouse brain predicting neur
neurodegeneration · archived Immune atlas neuroinflammation analysis in neurodegeneration
Neuroinflammation · archived Cell type vulnerability in Alzheimer's Disease (SEA-AD data)
neurodegeneration · failed Cell type vulnerability in Alzheimer's Disease (SEA-AD data
neurodegeneration · archived TREM2 Therapeutic Strategy Post-INVOKE-2
neurodegeneration · completed

Related Experiments (30)

AD Amyloid-Resilient Phenotype Study — Why Some amyloid-Posi
clinical · proposed · Score: 0.40 AD Combination Therapy Trial: Anti-Aβ + Anti-Tau
clinical · proposed · Score: 0.40 Alpha-Synuclein Aggregation Triggers — Sporadic PD Initiatio
clinical · proposed · Score: 0.40 Biomarker-Guided Sequential Therapy Selection in Alzheimer's
clinical · proposed · Score: 0.40 tACS Connectivity Trial in Early Alzheimer's
clinical · proposed · Score: 0.40

Cognitive Reserve Mechanisms in Alzheimer's Disease — Molecu
clinical · proposed · Score: 0.40 ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40 Exercise-BDNF-Mitophagy Biomarker Study in PD
clinical · proposed · Score: 0.40 Gut-Brain Axis Pathogenesis in Parkinson's Disease — Mechani
clinical · proposed · Score: 0.40 Lifestyle Intervention Mechanisms in Alzheimer's Disease
validation · proposed · Score: 0.40 Microbiome-Gut Barrier Signatures in ALS — Experiment Design
clinical · proposed · Score: 0.40 Sex Differences in Alzheimer's Disease — mechanisms and ther
clinical · proposed · Score: 0.40 Viral and Post-Infectious Mechanisms in ALS — Experiment Des
clinical · proposed · Score: 0.40 AAV Serotype Comparison for LRRK2 Knockdown in PD Gene Thera
validation · proposed · Score: 0.40 AAV-LRRK2 IND-Enabling Study Design
clinical · proposed · Score: 0.40 AAV Serotype Comparison for LRRK2 Knockdown in PD
validation · proposed · Score: 0.40 Alpha-Synuclein SAA Kinetics Study — Biological Staging Back
clinical · proposed · Score: 0.40 Computational Modeling of Alpha-Synuclein Propagation in PD
validation · proposed · Score: 0.40 Basic Mechanism: Membrane-Driven Alpha-Synuclein Nucleation
validation · proposed · Score: 0.40 Alpha-Synuclein Seed Amplification Assay Validation
clinical · proposed · Score: 0.40 Alpha-Synuclein Spreading Mechanism — Prion-Like Propagation
exploratory · proposed · Score: 0.40 Antiviral Therapy Trial for Parkinson's Disease
clinical · proposed · Score: 0.40 Astrocyte Ferritin Iron Metabolism Dysfunction in Parkinson'
clinical · proposed · Score: 0.40 Axonal Transport Dysfunction Validation in Parkinson's Disea
clinical · proposed · Score: 0.40 cGAS-STING Pathway Validation Study in Parkinson's Disease
clinical · proposed · Score: 0.40 Chaperone-Mediated Autophagy Dysfunction in PD - Experiment
clinical · proposed · Score: 0.40 Combination Therapy Sequencing in Parkinson's Disease
validation · proposed · Score: 0.40 CRISPR Gene Correction Approaches for CBS/PSP
clinical · proposed · Score: 0.40 Alpha-Synuclein Staging and Spreading in DLB — Spatial Propa
validation · proposed · Score: 0.40 DNA Damage Repair Deficiency Validation Study in Parkinson's
clinical · proposed · Score: 0.40

See Also (15)

Aging vs Neurodegeneration: Mechanistic Comparison Matr
mechanism · KG edge: activates Packard Center for ALS Research
institution · KG edge: associated_with Alzheimer Indonesia
institution · KG edge: activates AIM2 Inflammasome Modulation Therapy for Neurodegenerat
idea · KG edge: inhibits ADRB2 Gene
gene · KG edge: inhibits

ADAM10 — A Disintegrin And Metalloproteinase Domain 10
gene · KG edge: contributes_to OSK Reprogramming and Yamanaka Factors in Neurodegenera
mechanism · Pages share 5 hypotheses Wnt/β-Catenin Signaling Pathway in Neurodegeneration
mechanism · Pages share 4 hypotheses WNK1-Bilirubin Signaling in Neuroinflammation and Neuro
mechanism · Pages share 4 hypotheses vip-vasoactive-intestinal-peptide-signaling-neurodegene
mechanism · Pages share 4 hypotheses VEGF Signaling and Cerebral Angiogenesis in Neurodegene
mechanism · Pages share 4 hypotheses Vagus Nerve Pathway in Neurodegeneration
mechanism · Pages share 4 hypotheses Ubiquitin-Proteasome System Dysfunction in Neurodegener
mechanism · Pages share 4 hypotheses ubiquitin-proteasome-dysfunction-neurodegeneration
mechanism · Pages share 4 hypotheses Transdiagnostic Proteomic Changes in Neurodegeneration
mechanism · Pages share 4 hypotheses

Knowledge Graph (12 edges)

exercise activates PPARGC1A

exercise activates BDNF

exercise protects_against depression

exercise activates serotonin

exercise regulates BMAL1

exercise protects_against neuroinflammation

exercise activates hippocampal neurogenesis

exercise regulates neuroinflammation

exercise inhibits systemic inflammation

exercise modulates NRF2

SciDEX — scidex.ai — Dashboard | Atlas